Tevogen Bio (TVGN) Income Statement (2021 - 2026)
Income Statement report data from Apr 30, 2021 to Mar 31, 2026 for Tevogen Bio (TVGN).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Sep 30, 2021 | Jun 30, 2021 | Apr 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||
Research And Development | 3.13M (+48.34%) | 2.11M (-32.15%) | 3.11M (+15.19%) | 2.70M (-15.63%) | 3.20M (+12.68%) | 2.84M (-12.88%) | 3.26M (-20.87%) | 4.12M (-80.20%) | 21M (+2186.81%) | 910K (-18.75%) | 1.12M (+8.74%) | 1.03M (-23.70%) | 1.35M | - | - | - | - | - | - |
Selling General And Administrative | 2.27M (-9.20%) | 2.50M (-4.58%) | 2.62M (-4.38%) | 2.74M (-61.73%) | 7.16M (+9.65%) | 6.53M (+131.56%) | 2.82M (-36.91%) | 4.47M (-48.68%) | 8.71M (+691.82%) | 1.10M (-9.09%) | 1.21M (+5.22%) | 1.15M (+17.35%) | 980K (+366.67%) | 210K (+5.00%) | 200K (-23.08%) | 260K | - | 10K | - |
Operating Expenses | 5.40M (+17.14%) | 4.61M (-19.55%) | 5.73M (+5.33%) | 5.44M (-47.49%) | 10M (+10.68%) | 9.36M (+53.69%) | 6.09M (-29.19%) | 8.60M (-70.87%) | 30M (+1368.66%) | 2.01M (-13.73%) | 2.33M (+6.88%) | 2.18M (-6.03%) | 2.32M (+1004.76%) | 210K (+5.00%) | 200K (-23.08%) | 260K | - | 10K | - |
Depreciation And Amortization | 30K (-80.00%) | 150K | - | - | 40K (-66.67%) | 120K | - | - | 40K (-66.67%) | 120K | - | - | 40K | - | - | - | - | - | - |
Operating Income | |||||||||||||||||||
Operating Income | -5.40M (+17.14%) | -4.61M (-19.55%) | -5.73M (+5.33%) | -5.44M (-47.49%) | -10.36M (+10.68%) | -9.36M (+53.69%) | -6.09M (-29.19%) | -8.60M (-70.87%) | -29.52M (+1368.66%) | -2.01M (-13.73%) | -2.33M (+6.88%) | -2.18M (-6.03%) | -2.32M | - | - | - | - | - | - |
Ebit | -5.40M (+17.14%) | -4.61M (-19.55%) | -5.73M (+5.33%) | -5.44M (-47.49%) | -10.36M (+10.68%) | -9.36M (+53.69%) | -6.09M (-29.19%) | -8.60M (-70.87%) | -29.52M (+1368.66%) | -2.01M (-13.73%) | -2.33M (+6.88%) | -2.18M (-6.03%) | -2.32M | 2.61M (+62.11%) | 1.61M (+666.67%) | 210K | - | -10.00K (0.00%) | -10.00K |
EBITDA | -5.37M (+22.05%) | -4.40M (-23.21%) | -5.73M (+4.18%) | -5.50M (-46.71%) | -10.32M (+23.00%) | -8.39M (+42.93%) | -5.87M (-39.23%) | -9.66M (-67.23%) | -29.48M | 19M | -3.61M (-83.72%) | -22.18M (+872.81%) | -2.28M | 2.61M (+62.11%) | 1.61M (+666.67%) | 210K | - | -10.00K (0.00%) | -10.00K |
Other Income / Expenses | |||||||||||||||||||
Interest Income | - | - | - | - | - | - | - | - | - | 930K | - | - | 1.80M (-62.58%) | 4.81M | - | - | - | - | - |
Interest Expense | - | -20.00K | - | - | 20K (0.00%) | 20K (+100.00%) | 10K | - | 160K (-74.19%) | 620K (+106.67%) | 300K | - | 290K | - | - | - | - | - | - |
Net Interest Income | - | 20K | - | - | -20.00K (0.00%) | -20.00K (+100.00%) | -10.00K | - | -160.00K | 320K | -300.00K | - | 1.51M (-68.61%) | 4.81M | - | - | - | - | - |
Other Non Operating Income | - | - | - | - | - | - | - | - | - | 2.21M (+569.70%) | 330K (0.00%) | 330K (-80.92%) | 1.73M (-67.72%) | 5.36M (+196.13%) | 1.81M (+285.11%) | 470K | - | - | - |
Net Income | |||||||||||||||||||
Net Income From Continuing Operations | -5.45M (+16.45%) | -4.68M (-18.32%) | -5.73M (+4.18%) | -5.50M (-46.96%) | -10.37M (+9.85%) | -9.44M (+60.54%) | -5.88M (-39.13%) | -9.66M | 11M | -3.63M (-6.92%) | -3.90M (-82.42%) | -22.18M (-27.89%) | -30.76M | 2.61M (+62.11%) | 1.61M (+666.67%) | 210K | - | -10.00K (0.00%) | -10.00K |
Net Income | -5.45M (+16.45%) | -4.68M (-18.32%) | -5.73M (+4.18%) | -5.50M (-46.96%) | -10.37M (+9.85%) | -9.44M (+60.54%) | -5.88M (-39.13%) | -9.66M | 11M | -3.63M (-6.92%) | -3.90M (-82.42%) | -22.18M (-27.89%) | -30.76M | 2.61M (+62.11%) | 1.61M (+666.67%) | 210K | - | -10.00K (0.00%) | -10.00K |